Blog Rod Hochman, MD, president and CEO of Providence, is new Truveta Board of Directors Chair May 13, 2024 Real-world prescribing of lecanemab in the United States May 6, 2024 Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions May 6, 2024 New research uses Truveta Data to study the management of patients with acute heart failure May 2, 2024 Expanded clinical notes and medical images available to advance research May 1, 2024 Expanding customer options to achieve research success May 1, 2024 Truveta wins 2024 Stevie Awards for Most Innovative Company and Achievement in Technology April 25, 2024 Advancing maternal and pediatric research with the largest and most complete mother and child EHR dataset April 25, 2024 « Previous 1 … 27 28 29 … 44 Next »
Rod Hochman, MD, president and CEO of Providence, is new Truveta Board of Directors Chair May 13, 2024
Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions May 6, 2024
New research uses Truveta Data to study the management of patients with acute heart failure May 2, 2024
Truveta wins 2024 Stevie Awards for Most Innovative Company and Achievement in Technology April 25, 2024
Advancing maternal and pediatric research with the largest and most complete mother and child EHR dataset April 25, 2024